Addison Jonathan James

CRO Addison Jonathan James sold 23,304 shares (84.2% of holdings) at $77.10–$78.65 on 2026-03-25 for $1.8M; stock now $73.23, down 42.5% from 52-week high.

Addison Jonathan James, Chief Revenue Officer, executed three separate sales on 2026-03-25, divesting 23,304 shares for a blended average of $77.79—reducing his holdings from 27,668 shares to 4,364 shares, a net reduction of 84.2%. At the current price of $73.23, the blended sale price was 6.2% above current levels. His prior five sales at OKTA all registered negative 90-day returns, with a 100% well-timed rate at this ticker; the most recent sale on 2025-07-25 was followed by a 90d decline of -11.4%. His cross-ticker track record shows a 83.33% well-timed rate on 12 prior sells with an average 90d return of -2.5%, indicating a consistent pattern of selling ahead of downside. The timing of this substantial reduction—occurring near a 52-week high of $127.30—aligns with his established cadence, though the 42.5% drawdown from that peak to current price has already materialized.

Chief Revenue Officer Addison Jonathan James sold 6,091 shares of OKTA for $564,082.26 at blended average $92.61 on 2025-09-18.

Addison Jonathan James, Chief Revenue Officer of Okta, executed 4 separate sales totaling 6,091 shares for $564,082.26 on 2025-09-18, reducing his holdings from 13,158 shares to 7,067 shares (-46.3% vs pre-transaction holdings). At current price of $92.38, the stock is -27.4% from its 52-week high of $127.30 and has declined 6.2% over the past 90 days. The CRO's 5 prior OKTA-specific trades have all resulted in subsequent declines within 30 days (ranging from -0.9% to -8.0%), though 90-day outcomes are not yet measurable for those earlier trades. His broader cross-ticker track record shows prior sells with an average 90-day return of +3.3%, indicating that stock appreciation following his prior sales has been typical. Okta's valuation remains stretched (P/E 577.38) despite solid 15.3% annual revenue growth and $728.0M in latest-quarter revenue.

CRO Addison Jonathan James sold 9,000 OKTA shares at $100.00 on 2025-07-25; holds 7,067 post-sale.

Addison Jonathan James, Chief Revenue Officer, sold 9,000 shares (-56.0% of pre-transaction holdings) as part of a series of four additional sales within the prior 11 days (2025-07-14 through 2025-07-15). The aggregate reduction signals active disposition of OKTA equity. His cross-ticker track record shows a 33.33% well-timed sell rate across 7 prior open-market sales (90-day outcomes), with an average 90-day return of +3.3%, indicating past sales have generally captured moves before gains accrued. At the same ticker, his prior measurable sale (2025-04-11) returned -6.7% over 90 days, meeting the well-timed criterion for sells. Stock is currently $98.99, down -22.2% from its 52-week high of $127.30, though up +0.6% over 30 days. With a P/E of 618.69 and net income of $62,000,000.00 against revenue of $688,000,000.00, OKTA trades at an extreme multiple despite 15.3% annual revenue growth.

CRO Addison Jonathan James sold 9,027 shares at $91.78–$92.39 ($829,956.60), reducing holdings 36.0% in 4 separate transactions on July 14–15.

Addison Jonathan James, Chief Revenue Officer, executed 4 separate sales totaling 9,027 shares for $829,956.60 on July 14–15, at prices ranging from $91.70 to $92.39 (blended average $91.94), reducing his stake from 25,094 to 16,067 shares (-36.0%). His cross-ticker track record shows 3 prior sells with an average 90-day return of +3.3%, indicating a 33.33% well-timed rate. At OKTA specifically, his 3 prior sells showed mixed timing: one returned +18.0% over 30 days, but at the 90-day mark only 1 of 3 was well-timed (sales before declines). The stock is currently trading at $91.07, down 28.5% from the 52-week high of $127.30 and off 8.3% over the past 30 days, though the blended sale price of $91.94 was near today's current price. Okta's fundamentals remain solid with $688.0M revenue, $62.0M net income, and 15.3% annual revenue growth, though the P/E of 569.19 reflects significant premium valuation typical for high-growth software. The large absolute size and multi-transaction structure warrant attention to whether this reflects pre-planned rebalancing or discretionary activity, given the CRO's revenue-facing role and the timing during recent share price weakness.

CRO Addison Jonathan James sold 7,005 shares of OKTA at $101.19 on 2025-04-11; holds 19,067 shares post-sale.

Addison Jonathan James, Chief Revenue Officer, sold 7,005 shares at $101.19 on 2025-04-11, reducing his holdings by 26.9% to 19,067 shares. The stock currently trades at $100.21, down 14.1% from its 52-week high of $116.72, with a 30-day decline of 11.0% offset partially by a 90-day gain of 19.0%. His prior two sells at OKTA (both on 2024-10-14) posted positive 90-day returns of 8.7% and 7.9%, indicating poor timing in those instances—the stock rose after he sold. His cross-ticker track record shows a 90-day well-timed rate of 0.00%, meaning none of his 2 prior open-market sells across all stocks were followed by declines. The company shows solid fundamentals (15.3% annual revenue growth, $665.0M revenue), but carries a very high P/E of 626.31, reflecting either significant forward expectations or valuation risk. This sale does not follow a pattern of well-timed selling by this executive.

Okta CRO Addison Jonathan James sold 9,850 shares for $764,648.20 across 2 transactions on 2024-10-14

Addison Jonathan James, Chief Revenue Officer of Okta, executed 2 separate sales totaling 9,850 shares (9.8K shares) for $764,648.20 on 2024-10-14, reducing his holdings from 24,451 shares to 14,601 shares—a -40.3% reduction in post-transaction holdings. The blended average price of $77.63 compares to the current price of $75.72, showing the stock has traded lower since the sale. Okta's most recent quarter posted revenue of $646.0M with net income of $29.0M, though the company was unprofitable over its most recent full fiscal year. The stock is down -19.4% over the past 90 days and trades -32.1% from its 52-week high of $111.49, placing this sale in the context of material price weakness and prior full-year losses.